Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort ⟪ Real World Data in Lymphoma and Survival in Adults ⟫ (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital

被引:3
|
作者
Lan, Caroline L. E. [1 ]
Belot, Aurelien [2 ]
Golfier, Camille [3 ]
Audin, Berenice [3 ]
Sesques, Pierre [3 ]
Bernier, Adeline [2 ]
Safar, Violaine [3 ]
Marquet, Alexandra [2 ]
Ferrant, Emmanuelle [3 ]
Lazareth, Anne [3 ]
Lequeu, Helene [3 ]
Bouafia, Fadhela [3 ]
Karlin, Lionel [3 ]
Ghergus, Dana [3 ]
Maarek, Alizee [3 ]
Aussedat, Guillaume [3 ]
Idlhaj, Maryam [3 ]
Salles, Gilles [4 ]
Cherblanc, Fanny [2 ]
Bachy, Emmanuel [3 ]
Ghesquieres, Herve [3 ]
机构
[1] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Lyon, France
[2] Lyon Sud Univ Hosp, Lymphoma Acad Res Org, LYSARC, Pierre Benite, France
[3] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Pierre Benite, France
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA
关键词
D O I
10.1182/blood-2022-164552
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5210 / 5211
页数:2
相关论文
共 8 条
  • [1] Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
    Lan, Caroline Le
    Belot, Aurelien
    Golfier, Camille
    Audin, Berenice
    Sesques, Pierre
    Bernier, Adeline
    Safar, Violaine
    Ferrant, Emmanuelle
    Lazareth, Anne
    Lequeu, Helene
    Karlin, Lionel
    Ghergus, Dana
    Maarek, Alizee
    Aussedat, Guillaume
    Idlhaj, Maryam
    Salles, Gilles
    Cherblanc, Fanny
    Bachy, Emmanuel
    Ghesquieres, Herve
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [2] A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort
    Ghesquieres, Herve
    Rossi, Cedric
    Cherblanc, Fanny
    Le Guyader-Peyrou, Sandra
    Bijou, Fontanet
    Sujobert, Pierre
    Fabbro-Peray, Pascale
    Bernier, Adeline
    Belot, Aurelien
    Chartier, Loic
    Fornecker, Luc-Matthieu
    Baldi, Isabelle
    Bouabdallah, Krimo
    Laurent, Camille
    Oberic, Lucie
    Morineau, Nadine
    Le Gouill, Steven
    Morschhauser, Franck
    Haioun, Corinne
    Damaj, Gandhi
    Guidez, Stephanie
    Laboure, Gaelle
    Fitoussi, Olivier
    Lebras, Laure
    Gressin, Remy
    Salles, Gilles
    Ysebaert, Loic
    Monnereau, Alain
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [3] A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
    Hervé Ghesquières
    Cédric Rossi
    Fanny Cherblanc
    Sandra Le Guyader-Peyrou
    Fontanet Bijou
    Pierre Sujobert
    Pascale Fabbro-Peray
    Adeline Bernier
    Aurélien Belot
    Loic Chartier
    Luc-Matthieu Fornecker
    Isabelle Baldi
    Krimo Bouabdallah
    Camille Laurent
    Lucie Oberic
    Nadine Morineau
    Steven Le Gouill
    Franck Morschhauser
    Corinne Haioun
    Gandhi Damaj
    Stéphanie Guidez
    Gaëlle Labouré
    Olivier Fitoussi
    Laure Lebras
    Rémy Gressin
    Gilles Salles
    Loïc Ysebaert
    Alain Monnereau
    BMC Public Health, 21
  • [4] A French Multicentric Prospective Cohort of 6000 Patients with Integrative Epidemiological, Clinical, Biological and Treatment Data to Improve Knowledge on Outcome of Lymphoma Patients: Pilot Phase Results of the Real World Data in Lymphoma and Survival in Adults (REALYSA) Study
    Ghesquieres, Herve
    Rossi, Cedric
    Cherblanc, Fanny
    Le Guyader, Sandra
    Bijou, Fontanet
    Sujobert, Pierre
    Fabbro-Peray, Pascale
    Fornecker, Luc Mathieu
    Bernier, Adeline
    Baldi, Isabelle
    Bouabdallah, Krimo
    Laurent, Camille
    Oberic, Lucie
    Morineau, Nadine
    Salles, Gilles A.
    Ysebaert, Loic
    Monnereau, Alain
    BLOOD, 2019, 134
  • [5] First Line Therapy Evaluation Using Propensity Score Approach in Newly Diagnosed Advanced Classical Hodgkin Lymphoma Patients from Prospective Real-World Realysa Cohort and Phase 3 AHL2011 Trial
    Rossi, Cedric
    Marouf, Amira
    Fischer, Benedicte Deau
    Cherblanc, Fanny
    Cugnod, Emeline
    Chartier, Loic
    Fornecker, Luc Matthieu
    Andre, Marc
    Casasnovas, Rene-Olivier
    Ghesquieres, Herve
    BLOOD, 2023, 142
  • [6] Health-related quality of life and response shift effect of diffuse large B-cell lymphoma French relapse-free patients one year after diagnosis included in prospective real-life REALYSA cohort
    Anota, Amelie
    Charton, Emilie
    Basset, Mathurine
    Efficace, Fabio
    Hafirassou, Hadia
    Bernier, Adeline
    Belot, Aurelien
    Ghesquieres, Herve
    QUALITY OF LIFE RESEARCH, 2024, 33 : S49 - S49
  • [7] ALTERATIONS IN MICROBIAL COMPOSITION IN PATIENTS WITH NEWLY DIAGNOSED CROHN'S DISEASE OVER A COURSE OF ONE YEAR: DATA FROM A PROSPECTIVE LONGITUDINAL REAL-WORLD STUDY
    Fischler, Tali Sharar
    Reshef, Leah
    Godny, Lihi
    Friedenberg, Adi
    Pauker, Maor H.
    Rabinowitz, Keren M.
    Avni-Biron, Irit
    Gophna, Uri
    Dotan, Iris
    Yanai, Henit A.
    GASTROENTEROLOGY, 2024, 166 (05) : S558 - S558
  • [8] Alterations in microbial composition in patients with newly diagnosed Crohn's disease over a course of one year: data from a prospective longitudinal real-world study
    Fischler, T. Sharar
    Reshef, L.
    Godny, L.
    Freidenberg, A.
    Pauker, M.
    Rabinowitz, K.
    Avni-Biron, I.
    Gophna, U.
    Dotan, I.
    Yanai, H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2169 - I2170